Integral Diagnostics Limited
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as … Read more
Integral Diagnostics Limited (ITGDF) - Total Liabilities
Latest total liabilities as of June 2025: $732.53 Million USD
Based on the latest financial reports, Integral Diagnostics Limited (ITGDF) has total liabilities worth $732.53 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Integral Diagnostics Limited - Total Liabilities Trend (2019–2025)
This chart illustrates how Integral Diagnostics Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Integral Diagnostics Limited Competitors by Total Liabilities
The table below lists competitors of Integral Diagnostics Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangxi Xinyu Guoke Technology Co Ltd Class A
SHE:300722
|
China | CN¥211.24 Million |
|
Renew Energy Global PLC
NASDAQ:RNW
|
USA | $891.68 Billion |
|
Shanghai New World Co Ltd
SHG:600628
|
China | CN¥1.42 Billion |
|
Citizens & Northern Corp
NASDAQ:CZNC
|
USA | $2.79 Billion |
|
Zhonglu Co Ltd A
SHG:600818
|
China | CN¥549.01 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Integral Diagnostics Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Integral Diagnostics Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Integral Diagnostics Limited (2019–2025)
The table below shows the annual total liabilities of Integral Diagnostics Limited from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $732.53 Million | +65.52% |
| 2024-06-30 | $442.57 Million | -5.02% |
| 2023-06-30 | $465.96 Million | +6.93% |
| 2022-06-30 | $435.77 Million | +8.90% |
| 2021-06-30 | $400.16 Million | +13.64% |
| 2020-06-30 | $352.13 Million | +87.86% |
| 2019-06-30 | $187.45 Million | -- |